Search Results - "Lohman, J. J. H. M."

Refine Results
  1. 1

    Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy by Derijks, Luc J J, Gilissen, Lennard P L, Engels, Leopold G J B, Bos, Laurens P, Bus, Paul J, Lohman, Joseph J H M, Curvers, Wouter L, Van Deventer, Sander J H, Hommes, Daniel W, Hooymans, Piet M

    Published in Therapeutic drug monitoring (01-06-2004)
    “…Proper prospective pharmacokinetic studies of 6-mercaptopurine (6-MP) in inflammatory bowel disease (IBD) patients are lacking. As a result, conflicting…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease by DERIJKS, Luc J. J, GILISSEN, Lennard P. L, ENGELS, Leopold G. J. B, BOS, Laurens P, BUS, Paul J, LOHMAN, Joseph J. H. M, VAN DEVENTER, Sander J. H, HOMMES, Daniel W, HOOYMANS, Piet M

    Published in Therapeutic drug monitoring (01-02-2006)
    “…6-Thioguanine (6-TG) seems to be an attractive alternative in both AZA- and 6-MP-intolerant and -resistant IBD populations. However, little is known of 6-TG…”
    Get full text
    Journal Article
  3. 3

    Bioavailability of intranasal formulations of dihydroergotamine by VAN DER KUY, P.-H. M, LOHMAN, J. J. H. M, HOOYMANS, P. M, TER BERG, J. W. M, MERKUS, F. W. H. M

    Published in European journal of clinical pharmacology (01-11-1999)
    “…A comparison of the pharmacokinetic properties of two novel intranasal preparations of dihydroergotamine mesilate (DHEM) with a commercially available…”
    Get full text
    Journal Article
  4. 4

    6‐Thioguanine in azathioprine and 6‐mercaptopurine intolerant patients with inflammatory bowel disease by Derijks, L. J. J., De Jong, D. J., Gilissen, L. P. L., Engels, L. G. J. B., Mulder, C. J. J., Bos, L. P., Lohman, J. J. H. M., Hooymans, P. M.

    Published in British journal of clinical pharmacology (01-05-2002)
    “…Azathioprine (AZA) and 6‐mercaptopurine (6‐MP) are frequently used in the treatment of inflammatory bowel disease (IBD). However, about 10–20% of IBD‐patients…”
    Get full text
    Journal Article
  5. 5

    A quantification of the placebo response in migraine prophylaxis by van der Kuy, P-H M, Lohman, J J H M

    Published in Cephalalgia (01-05-2002)
    “…To quantify the placebo response of prophylactic therapy in migraine, a meta-analysis of prophylactic, double-blind, placebo controlled migraine studies was…”
    Get more information
    Journal Article
  6. 6

    Antimicrobial prophylaxis in hysterectomies : a double-blind, randomized, comparative study of a single dose of piperacillin (2g) versus a single dose of amoxicillin-clavulanic acid (2.2 g) by JANKNEGT, R, SCHEPERS, J, HAEST, J, FABIUS, G, LOHMAN, J

    Published in Infection (01-07-1993)
    “…A double-blind, randomized comparative study of piperacillin (2 g) versus amoxicillin-clavulanic acid (2.2 g) as a single dose 30 minutes before the initiation…”
    Get full text
    Journal Article
  7. 7

    Patterns of specific antimigraine drug use--a study based on the records of 18 community pharmacies by Lohman, J J H M, van der Kuy-de Ree, M M

    Published in Cephalalgia (01-03-2005)
    “…The objective of this study was, first, to characterize the usage patterns of specific antimigraine drugs, and second, to compare these in patients with one…”
    Get more information
    Journal Article
  8. 8

    Stability of amphotericin B in CAPD fluid by Janknegt, R, Paulissen, A, Hooymans, P M, Lohman, J J, Hermens, W A

    Published in Peritoneal dialysis international (01-01-1990)
    “…Amphotericin B is the drug of choice in continuous ambulatory peritoneal dialysis (CAPD) associated fungal peritonitis and is usually administered…”
    Get more information
    Journal Article
  9. 9

    Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study by van der Kuy, P-H M, Merkus, F W H M, Lohman, J J H M, ter Berg, J W M, Hooymans, P M

    Published in Cephalalgia (01-09-2002)
    “…Drugs which directly counteract nitric oxide (NO), such as endothelial receptor blockers, NO-synthase inhibitors, and NO-scavengers, may be effective in the…”
    Get more information
    Journal Article
  10. 10

    Effect of heparin on digitoxin protein binding by Lohman, J J, Hooymans, P M, Koten, M L, Verhey, M T, Merkus, F W

    Published in Clinical pharmacology and therapeutics (01-01-1985)
    “…Reduction of digitoxin binding to plasma proteins after heparin has been reported. Our aim was to determine whether this reduction is an in vivo effect or…”
    Get more information
    Journal Article
  11. 11
  12. 12

    A triptan too far? by VAN DER KUY, P-H M, LOHMAN, J J H M

    “…1 For sumatriptan 100 mg the therapeutic penalty is 17% (95% Cl 10%-24%) according to the text, but in figure 3 the penalty shown is about 8% (95% Cl 4%-12%)…”
    Get full text
    Journal Article
  13. 13

    Absorption of clonazepam after intranasal and buccal administration by Schols‐Hendriks, MW, Lohman, JJ, Janknegt, R, Korten, JJ, Merkus, FW, Hooymans, PM

    Published in British journal of clinical pharmacology (01-04-1995)
    “…Serum concentrations of clonazepam after intranasal, buccal and intravenous administration were compared in a cross‐over study in seven healthy male…”
    Get full text
    Journal Article
  14. 14

    Is Recormon less painful than Eprex after subcutaneous administration? by Hendriks, M W, Peters, F P, Hooymans, P M, Van de Wiel, T W, Janknegt, D, Janknegt, R, Lohman, J J

    “…In this study, we examined the differences in pain score after subcutaneous injection of the epoetin preparations Eprex and Recormon. Patients (n = 30)…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings by Hooymans, P M, Janknegt, R, Lohman, J J

    “…The sorption of clonazepam to polyvinyl chloride tubing, polyethylene-coated tubing and to a polyethylene syringe was determined. Pumping of clonazepam (5…”
    Get more information
    Journal Article
  17. 17

    Plasma protein binding of digitoxin and some other drugs in renal disease by Lohman, J J, Merkus, F W

    “…Plasma protein binding of most acidic drugs is decreased in uraemia, whereas the binding of basic drugs is usually unchanged or decreased. Decreased protein…”
    Get more information
    Journal Article
  18. 18

    Ofloxacin intravenous. Compatibility with other antibacterial agents by Janknegt, R, Stratermans, T, Cilissen, J, Lohman, J J, Hooymans, P M

    “…The physical and chemical compatibility of ofloxacin (infusion solution 100 ml = 200 mg) with amoxicillin, amoxicillin + clavulanic acid, flucloxacillin,…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Do evacuated blood collection tubes interfere with therapeutic drug monitoring? by Janknegt, R, Lohman, J J, Hooymans, P M, Merkus, F W

    “…The influence of various brands of evacuated blood collection systems (the old type, red stoppered Vacutainer; the new type, blue stoppered Vacutainer;…”
    Get more information
    Journal Article